Tillinghast Jeffrey P MD is categorized under Doctors in Saint Louis, MO and active since 2001.
Tillinghast Jeffrey P MD was established in 2001, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Jeffrey Tillinghast at the company’s single location by writing to 1040 North Mason Road # 115, Saint Louis, Missouri MO 63141 or by phoning (314) 542-0606. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Tillinghast Jeffrey P MD |
| Contact Person: | Jeffrey Tillinghast |
| Address: | 1040 North Mason Road # 115, Saint Louis, Missouri 63141 |
| Phone Number: | (314) 542-0606 |
| Website Address: | clinicalresearchcenter.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2001 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Tillinghast Jeffrey P MD was started in 2001 to provide professional Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Jeffrey Tillinghast for inquiries that concern Tillinghast Jeffrey P MD by calling the company number (314) 542-0606, as your correspondence is most welcome. Additionally, the physical location of the single location of Tillinghast Jeffrey P MD can be found at the coordinates 38.6766,-90.46982 as well as the street address 1040 North Mason Road # 115 in Saint Louis, Missouri 63141.
For its online presence, you may visit Tillinghast Jeffrey P MD’s website at clinicalresearchcenter.com and engage with its social media outlets through on Twitter and on Facebook.